Pfizer : PFE

All Pfizer Articles

1482 Articles

Lee Jackson | May 30, 2018 at 8:10 AM EDT

4 Dividend Stocks That Are Still Better Buys Than Bonds

These four stocks may not be as safe as U.S. Treasury debt, but they still would make great additions to…

Chris Lange | May 29, 2018 at 8:35 AM EDT

Meet Pfizer’s Newest FDA Designations

Pfizer announced early on Monday that it received a couple critical updates from the FDA related to its Xalkori (crizotinib).

Chris Lange | May 25, 2018 at 9:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 19, 2018 at 8:25 AM EDT

9 Companies Bracing for Big ASCO Reactions

This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.

Paul Ausick | May 18, 2018 at 9:45 AM EDT

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received…

Paul Ausick | May 14, 2018 at 4:01 PM EDT

UnitedHealth, Walmart Buoy the Dow Monday

UnitedHealth, Walmart, Pfizer, and DowDuPont did their best to pin a small gain on the Dow Monday.

Chris Lange | May 10, 2018 at 10:20 AM EDT

Short Sellers Run for Cover From Major Pharma

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | May 1, 2018 at 4:01 PM EDT

Pfizer, Merck Sink the Dow Tuesday

Pfizer, Merck, McDonald's, and Coca-Cola were the big losers Tuesday among the 30 Dow stocks.

Chris Lange | May 1, 2018 at 9:55 AM EDT

How Much Pfizer Earnings Depend on a Few Brands

Pfizer reported mixed first-quarter financial results and full-year guidance before the markets opened on Tuesday.

Chris Lange | Apr 30, 2018 at 1:25 PM EDT

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Both Pfizer and Merck are scheduled to release their most recent quarterly results before the markets open on Tuesday. These…

Trey Thoelcke | Apr 29, 2018 at 10:15 AM EDT

Apple, McDonald’s, Pfizer and Other Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of Apple, McDonald's, Pfizer and other Dow companies scheduled to report their…

Chris Lange | Apr 25, 2018 at 8:35 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Apr 17, 2018 at 11:35 AM EDT

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S.…

Chris Lange | Apr 11, 2018 at 1:25 PM EDT

Pfizer’s Kidney Drug Not Up to Par

Pfizer shares were relatively muted after the pharma giant provided an update for its late-stage kidney trial.

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 34 35 36 37 38 … 99

Pfizer : PFE

All Pfizer Articles

4 Dividend Stocks That Are Still Better Buys Than Bonds

Meet Pfizer’s Newest FDA Designations

Major Pharma Short Sellers Grow More Selective

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

UnitedHealth, Walmart Buoy the Dow Monday

Short Sellers Run for Cover From Major Pharma

Pfizer, Merck Sink the Dow Tuesday

How Much Pfizer Earnings Depend on a Few Brands

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Apple, McDonald’s, Pfizer and Other Dow Earnings Coming This Week

Short Sellers Grow More Selective on Major Pharma Stocks

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Pfizer’s Kidney Drug Not Up to Par

The Major Pharma Stocks That Are Making Short Sellers Sick

Google vs. Meta: Which Ad Giant Is the Better Long-Term Buy?

Top 5 Stocks That Will Profit From SpaceX’s NASA Launch Monopoly After Blue Origin’s Pad Collapse

$10,000 in Taiwan’s ETF Became $16,178 in Five Months While the S&P 500 Limped to $11,093

Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap

How Rich Do You Need to Be to Retire in Naples, Florida?

A $500,000 Roth Portfolio Loaded With JEPI Pays $42,250 a Year and the IRS Gets None of It

Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap

Pfizer : PFE

All Pfizer Articles

4 Dividend Stocks That Are Still Better Buys Than Bonds

Meet Pfizer’s Newest FDA Designations

Major Pharma Short Sellers Grow More Selective

9 Companies Bracing for Big ASCO Reactions

FDA Lists Brand-Name Drugmakers That Obstruct Generic Development

UnitedHealth, Walmart Buoy the Dow Monday

Short Sellers Run for Cover From Major Pharma

Pfizer, Merck Sink the Dow Tuesday

How Much Pfizer Earnings Depend on a Few Brands

What to Look For in the Merck and Pfizer Reports Tuesday Morning

Apple, McDonald’s, Pfizer and Other Dow Earnings Coming This Week

Short Sellers Grow More Selective on Major Pharma Stocks

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Pfizer’s Kidney Drug Not Up to Par

The Major Pharma Stocks That Are Making Short Sellers Sick

Google vs. Meta: Which Ad Giant Is the Better Long-Term Buy?

Top 5 Stocks That Will Profit From SpaceX’s NASA Launch Monopoly After Blue Origin’s Pad Collapse

$10,000 in Taiwan’s ETF Became $16,178 in Five Months While the S&P 500 Limped to $11,093

Featured Reads

Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap

How Rich Do You Need to Be to Retire in Naples, Florida?